Skip to main content

Table 3 Clinical response according to the genotype of TP53 SNP rs1042522

From: TP53 Arg72 as a favorable prognostic factor for Chinese diffuse large B-cell lymphoma patients treated with CHOP

Response Genotype P
  GG + GC (%) CC (%)
All patients
 CR 196(61) 33(44) 0.007
 PR + PD + SD 125(38.9) 42(56)
 OR 276(86) 57(76) 0.033
 PD + SD 45(14) 18(24)
Patients without Rituximab
 CR 38(45.8) 3(12.5) 0.004a
 PR + PD + SD 45(54.2) 21(87.5)
 OR 69(83.1) 18(75) 0.368
 PD + SD 14(16.9) 6(25)
Patients with Rituximab
 CR 158(66.4) 30(58.8) 0.304
 PR + PD + SD 80(33.6) 21(41.2)
 OR 207(87) 39(76.5) 0.056
 PD + SD 31(13) 12(23.5)
  1. CR Complete response
  2. PR Partial response
  3. PD Progression disease
  4. SD Stable disease
  5. OR Overall response
  6. a:Fisher’s Exact Test